Two things that stood out as the primary differences with a 30 second look from where CytoDyn currently is....ARQL trades on NYSE and has over 95% institutional ownership.
IMO is retail investors are getting the bargain of a lifetime at current prices....even more so those who are getting warrants at that price too. It will be a fun time once the party starts.
(1)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.